EUVIMEDEUVIMED entdecken
Open Access

Carbamylated Albumin, Heart Failure, and Mortality in Patients Undergoing Coronary Angiography

Babak Yazdani iD, Graciela E Delgado, Anders H Berg, Christoph Wanner iD, Bernhard K Krämer, Winfried März, Marcus E Kleber, Christiane Drechsler

Clinical Chemistry · 2025

DOI: 10.1093/clinchem/hvaf021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, 2025. Verfasst von Babak Yazdani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fifth Department of Medicine (Nephrology, Hypertensiology, Rheumatology, Endocrinology, Diabetology, Pneumology), University Medical Center Mannheim …. Hauptthemen laut MEDLINE: Heart Failure, Coronary Angiography, Serum Albumin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the H2020 Program TO_AITION, NHLBI NIH HHS, the 7th Framework Program RiskyCAD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Urea is elevated in chronic kidney disease (CKD) and end-stage renal disease (ESRD), and promotes the carbamylation of proteins, including human albumin, on multiple lysine side chains. Higher proportions of carbamylated albumin (C-Alb) have been associated with increased mortality risk in patients with ESRD. Whether C-Alb predicts mortality in patients with no or mild impairment of kidney function is unknown.

Methods

We measured C-Alb in 3197 participants of the Ludwigshafen Risk and Cardiovascular Health (LURIC) study who had been referred to coronary angiography and followed-up for 10 years. Association of baseline C-Alb with all-cause and cause-specific mortality was investigated using Cox proportional hazards regression.

Results

Higher quartiles of C-Alb were associated with a significantly increased risk of death from any cause, with hazard ratios (HRs, 95%CI) of 1.53 (1.26–1.85) and 2.52 (2.11–3.01) in the third and fourth quartiles, respectively. After adjustment for cardiovascular (CV) risk factors, including estimate glomerular filtration rate (eGFR), the association with mortality was attenuated with a HR of 1.25 (1.02–1.53) for the fourth quartile as compared to the first quartile. We observed the strongest association with death due to congestive heart failure (HF) with a HR of 7.19 (4.57–11.3) and 3.99 (2.40–6.63) per 1-unit increase of log-transformed C-Alb in unadjusted and multivariate adjusted analyses, respectively.

Conclusions

We observed a strong association of C-Alb with CV risk in patients with no or mild CKD. This association was independent of traditional CV risk factors including eGFR and particularly strong regarding death due to congestive HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureCoronary AngiographySerum AlbuminHumansMaleFemaleMiddle AgedAgedGlomerular Filtration RateProtein CarbamylationProportional Hazards ModelsRisk Factors

Substanzen

Serum Albumin

Autor:innen und Institutionen

  • Fifth Department of Medicine (Nephrology, Hypertensiology, Rheumatology, Endocrinology, Diabetology, Pneumology), University Medical Center Mannheim UMM, Faculty of Medicine of the University of Heidelberg, Mannheim, Ge…
  • European Center for Angioscience, Faculty of Medicine of the University of Heidelberg, Mannheim, Germany.
  • Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Department of Medicine 1, Division of Nephrology, University of Würzburg, Würzburg, Germany.
  • Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Synlab Academy, Synlab Holding Deutschland GmbH, Mannheim, Germany.

ORCID-Profile: Babak Yazdani, Christoph Wanner

Förderung

  • the H2020 Program TO_AITION
  • NHLBI NIH HHS
  • the 7th Framework Program RiskyCAD
  • the U.S. National Institutes of Health

Zitieren

APA

Yazdani, B., Delgado, G. E., Berg, A. H., Wanner, C., Krämer, B. K., März, W., Kleber, M. E., & Drechsler, C. (2025). Carbamylated Albumin, Heart Failure, and Mortality in Patients Undergoing Coronary Angiography. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvaf021

Vancouver

Yazdani B, Delgado GE, Berg AH, Wanner C, Krämer BK, März W, et al. Carbamylated Albumin, Heart Failure, and Mortality in Patients Undergoing Coronary Angiography. Clinical Chemistry. 2025. doi:10.1093/clinchem/hvaf021

BibTeX
@article{Yazdani2025,
  author = {Yazdani, Babak and Delgado, Graciela E and Berg, Anders H and Wanner, Christoph and Krämer, Bernhard K and März, Winfried and Kleber, Marcus E and Drechsler, Christiane},
  title = {Carbamylated Albumin, Heart Failure, and Mortality in Patients Undergoing Coronary Angiography},
  journal = {Clinical Chemistry},
  year = {2025},
  doi = {10.1093/clinchem/hvaf021}
}
Kostenlos starten →